Tenvie Therapeutics
Latest round
- Series A
Last raised
- Jan 2025
Total raised
- $200M
Investors
- 3
About Tenvie Therapeutics
, developer of small molecule therapies that target critical drivers of disease, including inflammation, metabolic dysfunction, and lysosomal dysfunction. In January 2025, Tenvie Therapeutics, Inc. Tenvie offers an advancing, comprehensive pipeline of small molecules to tackle a range of diseases affecting both the CNS and peripheral systems. The solution penetrant small molecules that cross the blood-brain barrier target diseases affecting the brain and nervous system and cross the blood-brain barrier effectively, as well as precision molecules that are restricted to peripheral areas of the body to address other conditions. Tenvie’s pipeline includes a variety of small molecules that are in various stages of development, targeting key drivers of disease progression in the CNS and peripheral systems. The therapeutic focus includes three primary disease mechanisms: inflammation, metabolic dysfunction, and lysosomal dysfunction.
Who invested in Tenvie Therapeutics
3 investors across 1 round
See all investors in Tenvie Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 8, 2025
Amount
$200M
Investors
Questions about Tenvie Therapeutics
Who invested in Tenvie Therapeutics?
Tenvie Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tenvie Therapeutics raised?
Tenvie Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Tenvie Therapeutics last raise money?
Tenvie Therapeutics's most recent round on record is a Series A, in Jan 2025.
What does Tenvie Therapeutics do?
, developer of small molecule therapies that target critical drivers of disease, including inflammation, metabolic dysfunction, and lysosomal dysfunction.
Where is Tenvie Therapeutics headquartered?
Tenvie Therapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like Tenvie Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tenvie Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Tenvie Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.